|
13 Jun 2007 |
Favrille Acquires Anti-CD20 Monoclonal Antibodies from Diversa
|
|
13 Jun 2007 |
Novo Nordisk opens new pilot plant for biopharmaceutical products in Hillerod, Denmark
|
|
13 Jun 2007 |
Penwest Begins Dosing Phase IIa Clinical Study of Nalbuphine ER
|
|
13 Jun 2007 |
Kissei and Eisai sign a license agreement to develop and commercialize Glufast(R), a rapid-acting insulin secretagogue in 10 ASEAN countries
|
|
13 Jun 2007 |
CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
|
|
13 Jun 2007 |
CombinatoRx and Angiotech Extend Research and Development Collaboration to Create Next Generation Drug Device and Local Delivery Medicines
|
|
12 Jun 2007 |
Merck Signs Strategic Alliance With Archemix
|
|
12 Jun 2007 |
Biotec Pharmacon enters Phase III with the diabetic ulcers indication
|
|
12 Jun 2007 |
NEOPHARM, Inc. Signs Exclusive License Agreement for the Use of CINTREDEKIN BESUDOTOX (IL13-PE38QQR) for the Treatment of Pulmonary Fibrosis and Asthma
|
|
12 Jun 2007 |
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
|
|
12 Jun 2007 |
Kurve Technology and Schering-Plough Sign Expanded Technology Agreement
|
|
12 Jun 2007 |
Archemix and Takeda to Enter into Collaboration for
|
|
12 Jun 2007 |
Coley Pharmaceutical Group Broadens Leading Toll-like Receptor (TLR) Platform Through Strategic Acquisition of 3M Company's TLR Therapeutic Research and Development Programs
|
|
09 Jun 2007 |
Mylan Announces Final FDA Approval for Doxycycline Tablets, 150mg
|
|
08 Jun 2007 |
Alkermes Announces Initiation of Phase I Clinical Study of AIR(R) Parathyroid Hormone
|
|
08 Jun 2007 |
BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
|
|
08 Jun 2007 |
BioMimetic Therapeutics Initiates Enrollment in E.U. Registration Trial for GEM OS(R)1 Bone Graft; U.S. GEM OS1 Pivotal Study Protocol Amended to Allow Shorter Follow-Up Time and More Patients
|
|
08 Jun 2007 |
Genzyme to Build New Biomanufacturing Plant to Support Growth of Thymoglobulin(R)
|
|
07 Jun 2007 |
Amgen to Acquire Alantos Pharmaceuticals, a Private Biotechnology Company in Cambridge, Massachusetts
|
|
07 Jun 2007 |
Abbott and Caprion Extend Partnership to Discover Antibody Targets for Cancer
|
|
06 Jun 2007 |
Inovio Biomedical Stops Enrollment of Phase III Clinical Trials for Head & Neck Cancer
|
|
06 Jun 2007 |
Unigene Reports That Oral Calcitonin Phase III Clinical Study for Osteoarthritis Treatment is Initiated
|
|
05 Jun 2007 |
Amgen to Acquire Ilypsa, a Private San Francisco Bay Area Biotechnology Company Focused on Kidney Disease Care
|
|
03 Jun 2007 |
ABRAXANE Demonstrates Longer Progression-Free Survival versus Taxotere in the Treatment of First-Line Metastatic Breast Cancer
|
|
02 Jun 2007 |
Indigo Pharmaceuticals, Inc. Signs License Agreement for INDI-702, a Drug for the Treatment of Arteriosclerosis Obliterans, With Nissan Chemical Industries and Taisho Pharmaceutical Co.
|
